LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/FDA Clears 1st Patient-Specific Humeral-Glenoid Shoulder Guides
Legal & Regulatory and Reimbursement

FDA Clears 1st Patient-Specific Humeral-Glenoid Shoulder Guides

December 23, 2019 2 min read Premium comments

Advertisement

FDA Clears 1st Patient-Specific Humeral-Glenoid Shoulder Guides
MyShoulder Placement Guides / Courtesy of Medacta International
#fda510kclearanceSecondary#shoulderreplacement#medactausa

On December 13, 2019, the FDA granted 510(k) clearance to Medacta USA’s MyShoulder Placement Guides, a shoulder prothesis system with anatomical guides for a single patient anatomy.

It took the agency almost nine month to find the device substantially equivalent to WrightTornier’s Blueprint. The clearance follows regulatory approval in Japan earlier this year.

The clearance document states the guides are patient-specific surgical instruments, “that allow for guided shoulder implants placement of both Medacta Shoulder Reverse System and Medacta Anatomic Shoulder Prosthesis and the additional products Glenoid Polyaxial Non-locking screws, Short Humeral Stem and Threaded Glenoid Baseplate.”

The device uses the patient’s CT Scan to perform a 3D planning of the glenohumeral joint replacement surgery. Then the humeral and glenoidal guides are created.

The company says this is the first patient-specific offering in the U.S. to provide both humeral and glenoid guides.

MyShoulder Placement Guides

According to the clearance document, the guides consist of the humeral guide, which is used to define the level and orientation of the humeral head resection cut, and, a glenoidal guide which is used to position and orient the K-wire that will subsequently guide the glenoidal reaming. Both anatomical and reverse total joint configurations are acceptable. Both humeral and glenoid guides are suitable for a delto-pectoral approach only.

The guides are single use, external communicating devices with limited (<24 hours) contact duration and are only provided in a non-sterile version.

Advertisement

Medacta Spine, Hip and Knee Offerings

The company has similar technologies for the spine, hip and knee. Company CEO Francesco Siccardi stated in a press release that the company has received “incredibly positive feedback from surgeons using our patient-matched solutions in joint and spine and are thrilled to bring this level of precision and collaboration to U.S. surgeons practicing shoulder arthroplasty as well.”

Matthew D. Saltzman, M.D., Associate Professor of Orthopaedic Surgery at the Northwestern Memorial Hospital in Chicago, Illinois, stated that working with the guides enables him “to play a key role in the surgical process from start to finish. Access to pre-operative planning and the support of a dedicated technician are key aspects of the platform and ensure the resulting guides are optimized for each procedure and patient.”

The company was established in 1999 in Switzerland.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy